Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Biogen PE Ratio 2006-2020 | BIIB

Current and historical p/e ratio for Biogen (BIIB) from 2006 to 2020. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Biogen PE ratio as of October 23, 2020 is 7.29.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
  
Biogen PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-10-23 265.00 10.29
2020-09-30 283.68 $25.75 11.02
2020-06-30 267.55 $34.14 7.84
2020-03-31 316.38 $32.40 9.76
2019-12-31 296.73 $31.47 9.43
2019-09-30 232.82 $28.12 8.28
2019-06-30 233.87 $26.88 8.70
2019-03-31 236.38 $23.21 10.18
2018-12-31 300.92 $21.60 13.93
2018-09-30 353.31 $15.47 22.84
2018-06-30 290.24 $14.11 20.57
2018-03-31 273.82 $14.00 19.56
2017-12-31 318.57 $11.92 26.73
2017-09-30 313.12 $16.31 19.20
2017-06-30 271.36 $15.23 17.82
2017-03-31 273.42 $15.95 17.14
2016-12-31 261.39 $16.92 15.45
2016-09-30 288.53 $17.70 16.30
2016-06-30 222.89 $17.14 13.00
2016-03-31 239.95 $16.28 14.74
2015-12-31 282.37 $15.34 18.41
2015-09-30 268.35 $15.31 17.53
2015-06-30 372.33 $14.78 25.19
2015-03-31 389.19 $13.86 28.08
2014-12-31 312.88 $12.39 25.25
2014-09-30 304.92 $10.57 28.85
2014-06-30 290.63 $9.00 32.29
2014-03-31 281.93 $8.05 35.02
2013-12-31 257.69 $7.82 32.95
2013-09-30 221.92 $7.13 31.12
2013-06-30 198.36 $6.75 29.39
2013-03-31 177.54 $6.30 28.18
2012-12-31 134.91 $5.76 23.42
2012-09-30 137.53 $5.75 23.92
2012-06-30 133.08 $5.51 24.15
2012-03-31 116.14 $5.08 22.86
2011-12-31 101.44 $5.03 20.17
2011-09-30 85.86 $4.80 17.89
2011-06-30 98.55 $4.42 22.30
2011-03-31 67.72 $4.36 15.53
2010-12-31 61.80 $3.96 15.61
2010-09-30 51.73 $4.03 12.84
2010-06-30 43.74 $3.93 11.13
2010-03-31 52.90 $3.30 16.03
2009-12-31 49.31 $3.34 14.76
2009-09-30 46.57 $2.98 15.63
2009-06-30 41.62 $2.73 15.24
2009-03-31 48.32 $2.94 16.43
2008-12-31 43.90 $2.64 16.63
2008-09-30 46.35 $2.61 17.76
2008-06-30 51.52 $2.32 22.21
2008-03-31 56.86 $2.16 26.33
2007-12-31 52.47 $2.00 26.23
2007-09-30 61.14 $1.65 37.05
2007-06-30 49.31 $1.69 29.18
2007-03-31 40.91 $0.65 62.93
2006-12-31 45.34 $0.63 71.97
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $41.056B $14.378B
Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia, and a deep clinical pipeline ranging from Alzheimer's disease, lupus nephritis to neuropathic pain.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $137.481B 10.59
Amgen (AMGN) United States $133.526B 14.50
CSL (CSLLY) Australia $96.688B 0.00
Gilead Sciences (GILD) United States $76.063B 10.95
Regeneron Pharmaceuticals (REGN) United States $61.253B 23.42
Vertex Pharmaceuticals (VRTX) United States $54.719B 30.53
Illumina (ILMN) United States $47.584B 55.33
Seattle Genetics (SGEN) United States $34.914B 0.00
Moderna (MRNA) United States $27.953B 0.00
BeiGene (BGNE) Cayman Islands $27.533B 0.00
Alexion Pharmaceuticals (ALXN) United States $26.228B 10.93
Genmab (GMAB) Denmark $23.186B 14.63
Genmab (GNMSF) Denmark $21.882B 5.04
Immunomedics (IMMU) United States $20.308B 0.00
Incyte (INCY) United States $19.790B 0.00
BioNTech SE (BNTX) Germany $19.540B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.882B 0.00
Bio-Rad Laboratories (BIO.B) United States $17.079B 77.25
Exact Sciences (EXAS) United States $16.081B 0.00
Horizon Therapeutics Public (HZNP) Ireland $15.703B 36.74
Alnylam Pharmaceuticals (ALNY) United States $15.575B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.357B 104.17
ARGENX SE-ADR (ARGX) Netherlands $11.857B 0.00
MyoKardia (MYOK) United States $11.774B 0.00
QIAGEN (QGEN) Netherlands $11.497B 29.18
Sarepta Therapeutics (SRPT) United States $10.818B 0.00
Bio-Techne Corp (TECH) United States $10.397B 71.34
Guardant Health (GH) United States $10.210B 0.00
Repligen (RGEN) United States $9.267B 147.09
Ascendis Pharma (ASND) Denmark $8.424B 0.00
Galapagos (GLPG) Belgium $8.081B 29.24
Mirati Therapeutics (MRTX) United States $8.028B 0.00
Exelixis (EXEL) United States $6.745B 24.53
ACADIA Pharmaceuticals (ACAD) United States $6.659B 0.00
Acceleron Pharma (XLRN) United States $6.552B 0.00
Adaptive Biotechnologies (ADPT) United States $6.373B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $6.327B 196.00
Novavax (NVAX) United States $5.735B 0.00
Blueprint Medicines (BPMC) United States $5.683B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.568B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.250B 14.34
Emergent Biosolutions (EBS) United States $5.168B 20.47
Vir Biotechnology (VIR) United States $4.735B 0.00
NeoGenomics (NEO) United States $4.689B 1415.33
Amicus Therapeutics (FOLD) United States $4.663B 0.00
Arena Pharmaceuticals (ARNA) United States $4.632B 0.00
China Biologic Products (CBPO) China $4.467B 26.52
Denali Therapeutics (DNLI) United States $4.337B 0.00
Halozyme Therapeutics (HALO) United States $4.260B 0.00
Fate Therapeutics (FATE) United States $4.143B 0.00
Reata Pharmaceuticals (RETA) United States $3.903B 0.00
Twist Bioscience (TWST) United States $3.888B 0.00
Insmed (INSM) United States $3.794B 0.00
Bluebird Bio (BLUE) United States $3.676B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.579B 0.00
Legend Biotech (LEGN) United States $3.549B 0.00
MorphoSys AG (MOR) Germany $3.473B 45.52
Global Blood Therapeutics (GBT) United States $3.467B 0.00
Eidos Therapeutics (EIDX) United States $2.854B 0.00
Alkermes (ALKS) Ireland $2.596B 54.40
I-Mab (IMAB) China $2.300B 0.00
PHARMA MAR SA (PHMMF) Spain $2.294B 0.00
Seres Therapeutics (MCRB) United States $2.170B 0.00
Sorrento Therapeutics (SRNE) United States $2.167B 0.00
Forma Therapeutics Holdings (FMTX) United States $2.023B 0.00
Editas Medicine (EDIT) United States $2.009B 0.00
Amarin (AMRN) Ireland $1.963B 0.00
Inovio Pharmaceuticals (INO) United States $1.883B 0.00
Beam Therapeutics (BEAM) United States $1.837B 0.00
UniQure (QURE) Netherlands $1.834B 0.00
Zymeworks (ZYME) Canada $1.830B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.817B 20.35
Viela Bio (VIE) United States $1.755B 0.00
Intra-Cellular Therapies (ITCI) United States $1.733B 0.00
Revance Therapeutics (RVNC) United States $1.576B 0.00
Northwest Biotherapeutics (NWBO) United States $1.515B 0.00
Sangamo Therapeutics (SGMO) United States $1.502B 0.00
Zealand Pharma (ZEAL) Denmark $1.483B 0.00
Zealand Pharma (ZLDPF) Denmark $1.483B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.465B 0.00
Intellia Therapeutics (NTLA) United States $1.457B 0.00
Epizyme (EPZM) United States $1.377B 0.00
Ligand Pharmaceuticals (LGND) United States $1.362B 46.05
Mesoblast (MESO) Australia $1.320B 0.00
Arcus Biosciences (RCUS) United States $1.320B 0.00
Mersana Therapeutics (MRSN) United States $1.273B 0.00
Coherus BioSciences (CHRS) United States $1.215B 7.08
NGM Biopharmaceuticals (NGM) United States $1.170B 0.00
Alcobra (ARCT) United States $1.157B 0.00
Cytokineticsorporated (CYTK) United States $1.144B 0.00
Heska (HSKA) United States $1.141B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.111B 0.00
Myriad Genetics (MYGN) United States $1.103B 0.00
Retrophin (RTRX) United States $1.073B 0.00
REGENXBIO (RGNX) United States $1.064B 0.00
Genetron Holdings (GTH) China $1.025B 0.00
Castle Biosciences (CSTL) United States $1.010B 0.00
Adverum Biotechnologies (ADVM) United States $0.991B 0.00
Compugen (CGEN) Israel $0.976B 0.00
Athenex (ATNX) United States $0.973B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.965B 0.00
Vericel (VCEL) United States $0.914B 0.00
NantKwest (NK) United States $0.868B 0.00
Codexis (CDXS) United States $0.840B 0.00
Morphic Holding (MORF) United States $0.824B 0.00
Pliant Therapeutics (PLRX) United States $0.818B 0.00
Arvinas (ARVN) United States $0.807B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.798B 0.00
Intrexon (PGEN) United States $0.774B 0.00
Cellectis S.A (CLLS) France $0.758B 0.00
Alector (ALEC) United States $0.751B 0.00
Agenus (AGEN) United States $0.748B 0.00
Protagonist Therapeutics (PTGX) United States $0.744B 0.00
Frequency Therapeutics (FREQ) United States $0.737B 0.00
MiMedx (MDXG) United States $0.708B 0.00
AnaptysBio (ANAB) United States $0.708B 0.00
Pharming Group (PHGUF) Netherlands $0.692B 15.79
Cara Therapeutics (CARA) United States $0.670B 0.00
Celldex Therapeutics (CLDX) United States $0.645B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
VBI Vaccines (VBIV) United States $0.603B 0.00
Kadmon Holdings (KDMN) United States $0.599B 0.00
Geron (GERN) United States $0.584B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.584B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.580B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.559B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.556B 4.87
IVERIC Bio (ISEE) United States $0.537B 0.00
Cel-Sci (CVM) United States $0.531B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.528B 0.00
Albireo Pharma (ALBO) United States $0.527B 0.00
Anika Therapeutics (ANIK) United States $0.511B 22.32
Clovis Oncology (CLVS) United States $0.496B 0.00
MeiraGTx Holdings (MGTX) United States $0.489B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.486B 0.00
MannKind (MNKD) United States $0.481B 0.00
Prothena (PRTA) Ireland $0.472B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.471B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.465B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.464B 0.00
Avid Bioservices (CDMO) United States $0.461B 0.00
Dynavax Technologies (DVAX) United States $0.460B 0.00
Sutro Biopharma (STRO) United States $0.454B 0.00
Kala Pharmaceuticals (KALA) United States $0.437B 0.00
Amryt Pharma (AMYT) United Kingdom $0.436B 0.00
UROGEN PHARMA (URGN) United States $0.428B 0.00
Scholar Rock Holding (SRRK) United States $0.413B 0.00
Starpharma Holdings (SPHRY) Australia $0.413B 0.00
Cue Biopharma (CUE) United States $0.401B 0.00
Merus (MRUS) Netherlands $0.377B 0.00
Puma Biotechnology (PBYI) United States $0.376B 0.00
Kamada (KMDA) Israel $0.371B 17.72
Forte Biosciences (FBRX) United States $0.367B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.366B 0.00
Spero Therapeutics (SPRO) United States $0.362B 0.00
Precision BioSciences (DTIL) United States $0.359B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.358B 0.00
Cellular Biomedicine (CBMG) United States $0.357B 0.00
IBio (IBIO) United States $0.357B 0.00
Trevena (TRVN) United States $0.349B 0.00
AC Immune SA (ACIU) Switzerland $0.342B 0.00
ANI Pharmaceuticals (ANIP) United States $0.341B 8.06
Syros Pharmaceuticals (SYRS) United States $0.340B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.336B 0.00
BioDelivery Sciences (BDSI) United States $0.328B 23.21
Athersys (ATHX) United States $0.328B 0.00
Cardiff Oncology (CRDF) United States $0.317B 0.00
NextCure (NXTC) United States $0.316B 0.00
Innate Pharma S.A (IPHA) France $0.313B 0.00
CytomX Therapeutics (CTMX) United States $0.312B 0.00
ChromaDex (CDXC) United States $0.306B 0.00
WAVE Life Sciences (WVE) Singapore $0.303B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.302B 0.00
Selecta Biosciences (SELB) United States $0.288B 0.00
Affimed (AFMD) Germany $0.251B 0.00
PDL BioPharma (PDLI) United States $0.250B 0.00
Pluristem Therapeutics (PSTI) Israel $0.248B 0.00
TELA Bio (TELA) United States $0.243B 0.00
Fortress Biotech (FBIO) United States $0.236B 0.00
Arbutus Biopharma (ABUS) United States $0.235B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.232B 0.00
XOMA (XOMA) United States $0.219B 0.00
HOOKIPA Pharma (HOOK) United States $0.212B 0.00
Verastem (VSTM) United States $0.209B 0.00
Dyadic (DYAI) United States $0.204B 0.00
Five Prime Therapeutics (FPRX) United States $0.200B 0.00
ADMA Biologics Inc (ADMA) United States $0.198B 0.00
Eton Pharmaceuticals (ETON) United States $0.192B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.187B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
CorMedix Inc (CRMD) United States $0.177B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.171B 0.00
Liquidia Technologies (LQDA) United States $0.170B 0.00
Biofrontera AG (BFRA) Germany $0.170B 0.00
Cerecor (CERC) United States $0.169B 0.00
GENFIT S.A (GNFT) France $0.168B 0.00
DBV Technologies S.A (DBVT) France $0.166B 0.00
Kindred Biosciences (KIN) United States $0.163B 0.00
Theratechnologies (THTX) Canada $0.159B 0.00
VolitionRX (VNRX) United States $0.155B 0.00
Aptinyx (APTX) United States $0.149B 0.00
Bellus Health (BLU) Canada $0.149B 0.00
Nicox SA (NICXF) France $0.149B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.148B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.146B 6.80
Checkpoint Therapeutics (CKPT) United States $0.143B 0.00
Exicure (XCUR) United States $0.140B 0.00
Prometic Life Sciences (LMNL) Canada $0.140B 0.00
Applied Genetic Technologies (AGTC) United States $0.139B 0.00
SESEN BIO, INC (SESN) United States $0.138B 0.00
Cidara Therapeutics (CDTX) United States $0.137B 0.00
AquaBounty Technologies (AQB) United States $0.129B 0.00
Aytu Bioscience (AYTU) United States $0.127B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.118B 0.00
VTv Therapeutics (VTVT) United States $0.118B 0.00
Lumos Pharma (LUMO) United States $0.116B 0.00
Catalyst Biosciences (CBIO) United States $0.116B 0.00
Protalix BioTherapeutics (PLX) Israel $0.115B 0.00
Celyad SA (CYAD) Belgium $0.115B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.113B 0.00
Strongbridge Biopharma (SBBP) United States $0.113B 0.00
Windtree Therapeutics (WINT) United States $0.112B 0.00
Gritstone Oncology (GRTS) United States $0.111B 0.00
Orgenesis (ORGS) United States $0.110B 5.60
Unum Therapeutics (COGT) United States $0.110B 0.00
Abeona Therapeutics (ABEO) United States $0.108B 0.00
Antibe Therapeutics (ATBPF) Canada $0.104B 0.00
AIT Therapeutics (XAIR) United States $0.102B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.100B 0.00
Enzo Biochem (ENZ) United States $0.099B 0.00
Oncobiologics (OTLK) United States $0.094B 0.00
Palatin Technologies (PTN) United States $0.093B 0.00
Cyclerion Therapeutics (CYCN) United States $0.092B 0.00
Ecology Coatings (ABVC) United States $0.086B 0.00
ARAVIVE, INC (ARAV) United States $0.083B 0.00
Evogene (EVGN) Israel $0.082B 0.00
DiaMedica Therapeutics (DMAC) United States $0.079B 0.00
Stealth BioTherapeutics (MITO) United States $0.077B 73.50
Bionano Genomics (BNGO) United States $0.075B 0.00
Idera Pharmaceuticals (IDRA) United States $0.075B 0.00
Prima BioMed (IMMP) Australia $0.069B 0.00
Synlogic (SYBX) United States $0.068B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.068B 0.00
Organovo Holdings (ONVO) United States $0.068B 0.00
Adocia (ADOCY) France $0.067B 0.00
Clearside Biomedical (CLSD) United States $0.066B 0.00
Appili Therapeutics (APLIF) Canada $0.065B 0.00
AmpliPhi Biosciences (ARMP) United States $0.064B 0.00
Curis (CRIS) United States $0.064B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.063B 0.00
Edesa Biotech (EDSA) Canada $0.061B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.060B 0.00
Proteostasis Therapeutics (PTI) United States $0.058B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.057B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.056B 0.00
TRACON Pharmaceuticals (TCON) United States $0.053B 0.00
Soligenix (SNGX) United States $0.049B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
Genetic Technologies (GENE) Australia $0.046B 0.00
Happiness Biotech Group (HAPP) China $0.045B 0.00
Cocrystal Pharma (COCP) United States $0.045B 0.00
Novogen (KZIA) Australia $0.043B 0.00
Acorda Therapeutics (ACOR) United States $0.042B 0.00
IMMURON (IMRN) Australia $0.041B 0.00
Pulmatrix (PULM) United States $0.039B 0.00
AnPac Bio-Medical Science (ANPC) China $0.039B 0.00
CollPlant Holdings (CLGN) Israel $0.039B 0.00
Chanticleer Holdings (SONN) United States $0.038B 0.00
Vaccinex (VCNX) United States $0.038B 0.00
Apricus Biosciences (SEEL) United States $0.036B 0.00
OvaScience (MLND) United States $0.035B 0.00
Cleveland BioLabs (CBLI) United States $0.034B 0.00
ATyr Pharma (LIFE) United States $0.033B 0.00
Advaxis (ADXS) United States $0.033B 0.00
Signal Genetics (MGEN) United States $0.027B 0.00
BioCardia (BCDA) United States $0.027B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.024B 0.00
Alimera Sciences (ALIM) United States $0.023B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
Prana Biotechnology (ATHE) Australia $0.023B 0.00
Aptevo Therapeutics (APVO) United States $0.023B 0.00
Celsion (CLSN) United States $0.021B 0.00
Spherix (AIKI) United States $0.020B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.020B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
Cesca Therapeutics (THMO) United States $0.016B 0.00
BioPharmX (TMBR) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Titan Pharmaceuticals (TTNP) United States $0.013B 0.00
Neuralstem (SNCA) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
GeoVax Labs (GOVX) United States $0.002B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00